Creso Pharma’s cannabis production facility is currently under construction in West Hants, Nova Scotia. According to documents from the Australia-based company’s website, the site is approximately 20,000 square feet and could produce between 2,000 and 4,000 kilograms of cannabis annually. – Colin Chisholm

WEST HANTS, N.S. — The Windsor-West Hants Industrial Park will soon have a new tenant, just in time for Canada’s plan to legalize marijuana. 

Creso Pharma, a publicly traded company based in Australia, is hoping that the impending legalization of marijuana in Canada, will be a boon for its growing cannabis industry, which includes supplying recreational and medical marijuana products. 

Although the company has yet to confirm directly to the Valley Journal-Advertiser the location of the facility, construction of a large structure on Ivey Lane is emblazoned with the Creso Pharma logo. 

A PDF on the company’s website also details progress of the new, 20,000-square-foot facility in Nova Scotia, Canada, with images that match the Windsor-West Hants Industrial Park location. 

“We are very pleased that construction of the production facility is progressing well with site works such as the formation of roads and driveways and land excavation now complete as well as the installation of services including water, sewer, drainage and power,” Creso Pharma co-founder and chief executive officer Dr. Miri Halperin Wernli said in the press release.

“The Canadian market represents a significant opportunity for Creso and we look forward to completing construction by Q3 2018 which will allow us to capitalise on the huge market opportunity in Canada once recreational cannabis is legalised in addition to medicinal cannabis.”

Creso’s expansion into Canada was made possible after acquiring Mernova Medicinal Inc., a Nova Scotia-based company, which is now a subsidiary of Creso. 

According to documents on Creso’s website, the facility is expected to be

Read More Here...